Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 469 Neoplasms 327 Colorectal Neoplasms 236 Carcinoma, Non-Small-Cell Lung 233 Lung Neoplasms 200 Prostatic Neoplasms 179 Carcinoma, Hepatocellular 173 Stomach Neoplasms 138 Pancreatic Neoplasms 126 Leukemia, Myeloid, Acute 114 Uterine Cervical Neoplasms 110 Rectal Neoplasms 105 Multiple Myeloma 93 Recurrence 88 Squamous Cell Carcinoma of Head and Neck 84 Head and Neck Neoplasms 78 Neoplasm Metastasis 76 Ovarian Neoplasms 75 Brain Neoplasms 69 Colonic Neoplasms 68 Glioblastoma 66 Esophageal Neoplasms 66 Triple Negative Breast Neoplasms 65 Endometrial Neoplasms 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Small Cell Lung Carcinoma 54 Disease 54 Motor Activity 53 Hematologic Neoplasms 53 Glioma 46

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × OTHER × ER+HER2- Breast Cancer × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡